No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Kiromic Biopharma Inc: Terminated Brian Hungerford Co's Chief Financial Officer
Express News | Kiromic Biopharma Inc Files for Offering up to 1 Mln Units
Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival
Kiromic BioPharma | 10-K: FY2024 Annual Report
Kiromic Files to Raise $17M Through Uplisting
Kiromic Biopharma, Now on OTCQB, Files to Offer Units Consisting of Stock and Warrants and Seeks NYSE American Listing